Dillon Sue

Biography

  Sue Dillon, Ph.D. has end-to-end responsibility for immunology drug discovery, biomarkers, translational medicine, clinical development and life cycle management for a number of industry-leading products. She leads a global team focused on combining internal and external innovation approaches to discover and develop new solutions for patients with serious autoimmune diseases. Sue is also responsible for management of the Janssen institute, Covagen LLC and Janssen Immunosciences. An experienced leader in R&D, Sue has held senior positions at large pharmaceutical companies and biotechs. Sue joined the Johnson & Johnson Family of Companies as Vice President, Centocor R&D Discovery Research in 2001 and has held positions of increasing responsibility leading to her 2009 appointment to her current role as Global Therapeutic Area Head for Immunology. During her tenure, the Immunology Therapeutic Area has continued to build a strong immunology portfolio and pipeline of innovative assets in early development and discovery. 

Research Interest

drug discovery, biomarkers, translational medicine, clinical development